PharmaBoardroom

Five Ways That AI Can Transform Pharma Market Access

Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland outlines how AI has already begun to transform pharmaceutical…

Turkey: A Question of Timing: Negative Declaratory Relief in…

Istanbul’s First Instance IP Court recently dismissed a negative declaratory action (the “Case”) against our client citing the plaintiff’s…

René P Buholzer – CEO, Interpharma, Switzerland

Interpharma’s Dr René P. Buholzer highlights the key lessons that Switzerland’s innovative pharmaceutical industry has taken from the COVID-19…

Industry Warns of Vaccine Manufacturing Bottlenecks; Specific…

Big Pharma’s representatives are warning of upcoming bottlenecks in the COVID-19 vaccine manufacturing supply chain and are asking for a unified…

Opportunities for the Life Science Industry in Australia…

Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully managed to avoid the worst of the…

Takeda Pivoting to Growth Amid Renewed Focus on “Core Assets”

“This marks a significant moment in Takeda’s history and is an exciting step forward as we accelerate our transformation journey,” said…

India Pharma News: Global Implications of COVID Crisis; April…

The latest from Indian pharma, including the year-to-year 51.5 percent growth of the pharma market in April, Lilly’s partnership with three generics…

Varian’s Kenneth Tan on the Future of Cancer Care in APAC

Kenneth Tan has been President for Asia Pacific & Japan at cancer-focused medical device player Varian since February 2019. In a recent…

APAC: Self-Medication in the Age of COVID: The Country-Specific…

Writing in the May edition of DIA’s Global Forum magazine, Toshiyoshi Tominaga of the Asia-Pacific Self-Medication Industry (APSMI) looks at the…

APAC: Generic Penetration by Country

Generics penetration in the Asia-Pacific region by country for 2018. A full 90.3 percent of all medicines dispensed in India were generics compared to…

Ng Huck Hui – Assistant Chief Executive, Biomedical…

Professor Ng Huck Hui of A*Star's Biomedical Research Council outlines the evolution of Singapore's science and technology research and innovation…

Piers Ingram – Co-Founder & CEO, Hummingbird…

Dr Piers Ingram, PhD, co-founder, and CEO of Singapore-based biotech Hummingbird Bioscience, shares his motivation for establishing the company in…

Tagged with P